Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity
{{output}}
Dose-limiting toxicities remain a major barrier to drug development and therapy, revealing the limited predictive power of human genetics. Here, we demonstrate the utility of a more comprehensive approach to studying drug toxicity through longitudinal profilin... ...
